SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-23-000101
Filing Date
2023-09-12
Accepted
2023-09-12 07:13:45
Documents
14
Period of Report
2023-09-08
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20230908.htm   iXBRL 8-K 35928
2 EX-99.1 a91223pr.htm EX-99.1 35558
6 image_0.jpg GRAPHIC 31087
  Complete submission text file 0001860782-23-000101.txt   257518

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20230908.xsd EX-101.SCH 2010
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20230908_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20230908_pre.xml EX-101.PRE 13144
8 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20230908_htm.xml XML 2808
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 231249003
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences